Imago BioSciences, Inc. Comprehensive Income
Imago BioSciences, Inc. reported Comprehensive Income of -$16.76 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-11-09
- Imago BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$16.76M.
- Imago BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$13.93M.
- Imago BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-03-31 was -$16.99M.
- Imago BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was -$14.79M.
- Imago BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$42.35M.
- Imago BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$17.84M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$16.76M 10-Q · filed 2022-11-09 | -$30.70M derived: sum of 2 quarters · filed 2022-11-09 | -$47.68M 10-Q · filed 2022-11-09 | -$62.47M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | -$13.93M 10-Q · filed 2022-08-12 | -$30.92M 10-Q · filed 2022-08-12 | -$45.70M derived: sum of 3 quarters · filed 2022-08-12 | -$57.38M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | -$16.99M 10-Q · filed 2022-05-12 | -$31.77M derived: sum of 2 quarters · filed 2022-05-12 | -$43.44M derived: sum of 3 quarters · filed 2022-11-09 | -$52.24M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | -$14.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$26.46M derived: sum of 2 quarters · filed 2022-11-09 | -$35.25M derived: sum of 3 quarters · filed 2022-11-09 | -$42.35M 10-K · filed 2022-03-24 |
| 2021-09-30 | -$11.67M 10-Q · filed 2022-11-09 | -$20.47M derived: sum of 2 quarters · filed 2022-11-09 | -$27.57M 10-Q · filed 2022-11-09 | -$33.13M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$8.80M 10-Q · filed 2022-08-12 | -$15.89M 10-Q · filed 2022-08-12 | -$21.46M derived: sum of 3 quarters · filed 2022-08-12 | -$25.76M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$7.10M 10-Q · filed 2022-05-12 | -$12.66M derived: sum of 2 quarters · filed 2022-05-12 | -$16.96M derived: sum of 3 quarters · filed 2022-05-12 | -$20.70M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$9.87M derived: sum of 2 quarters · filed 2022-03-24 | -$13.60M derived: sum of 3 quarters · filed 2022-03-24 | -$17.84M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$4.31M 10-Q · filed 2021-11-10 | -$8.04M derived: sum of 2 quarters · filed 2021-11-10 | -$12.28M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$3.73M 10-Q · filed 2021-08-19 | -$7.97M 10-Q · filed 2021-08-19 |